{'fraction_non_alphanumeric': 0.02768166089965398, 'fraction_numerical': 0.0, 'mean_word_length': 5.944, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Mission accomplished? Early data from the simultaneous liver‐kidney transplantation allocation policy

Dual organ transplantation offers a unique ethical and resource allocation dilemma, whereby competing interests across the patient, provider, and transplant center spectrum play into the decision-making process. On the one hand, patients with decompensated cirrhosis have a high risk of acute kidney injury (AKI) and have chronic conditions that predispose them to chronic kidney disease (CKD). For these populations, simultaneous liver kidney transplantation (SLKT) has traditionally had superior survival as compared to liver transplantation alone (LTA), leading to centers to preferentially choose SLKT. On the other hand, kidney transplant alone (KTA) in patients without liver disease also offers a survival advantage as compared to remaining on the waitlist.